Sension

Executive Summary

Sension is a privately held, accredited medical laboratory based in Munich, Germany, founded in 2020. The company offers a broad range of diagnostic tests for both human and animal samples, including Vitamin D, antibody tests for measles, mumps, rubella, tetanus, and other specialized assays such as KPU (Kryptopyrroluria) and acid-base balance. By serving therapists and direct customers, Sension positions itself as a reliable partner in preventive and functional medicine. While the company operates in a competitive diagnostics market, its accreditation and comprehensive test menu provide a foundation for growth. However, the lack of disclosed funding, valuation, or revenue data makes it challenging to assess financial traction. Sension's focus on niche tests and dual human-veterinary offering may differentiate it from larger labs. Future success will depend on scaling operations, expanding test capabilities, and forging partnerships to increase sample throughput. The company's regional presence in Germany offers opportunities for domestic expansion but also limits exposure to international markets. Overall, Sension appears to be a small but specialized lab with moderate growth potential in the diagnostics sector.

Upcoming Catalysts (preview)

• Q3 2026Launch of novel autoimmune diagnostic panel60% success
• TBDPartnership with telemedicine platforms for sample collection50% success
• Q4 2026Expansion of veterinary diagnostic service offerings55% success